2018
DOI: 10.1016/j.chempr.2018.08.003
|View full text |Cite
|
Sign up to set email alerts
|

A Massively Parallel Selection of Small Molecule-RNA Motif Binding Partners Informs Design of an Antiviral from Sequence

Abstract: SUMMARY Many RNAs cause disease; however, RNA is rarely exploited as a small-molecule drug target. Our programmatic focus is to define privileged RNA motif small-molecule interactions to enable the rational design of compounds that modulate RNA biology starting from only sequence. We completed a massive, library-versus-library screen that probed over 50 million binding events between RNA motifs and small molecules. The resulting data provide a rich encyclopedia of small-molecule RNA recognition patterns, defin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
51
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 45 publications
(52 citation statements)
references
References 63 publications
1
51
0
Order By: Relevance
“…These interactions fine-tune the specificity of RNA interactions by determining structure at the 3D level [22]. Interestingly, non-canonical pairs were also found to be involved in ligand binding sites [8,19], which corroborates with further findings showing that some secondary structure motifs can specify ligand binding [6,48].…”
Section: Rna Structuresupporting
confidence: 74%
“…These interactions fine-tune the specificity of RNA interactions by determining structure at the 3D level [22]. Interestingly, non-canonical pairs were also found to be involved in ligand binding sites [8,19], which corroborates with further findings showing that some secondary structure motifs can specify ligand binding [6,48].…”
Section: Rna Structuresupporting
confidence: 74%
“…Dysregulation of AP-1 is hallmark of viral pathogenesis, neoplastic transformation and tumor progression (35,46). Likewise, dysregulation of dhx9/rha is associated with productive viral infection (31,37,38,45,(47)(48)(49)(50) and tumor survival (51)(52)(53)(54). The recent finding NCBP3 is essential to mount a precise antiviral response (34) posits dysfunction in a RHA-NCBP1-NCBP3 translation pathway contributes to deficient innate response.…”
Section: Discussionmentioning
confidence: 99%
“…Tertiary modeling of polypeptide conformations has been integral to elucidating the functional mechanisms of enzymes, chaperones, many structural proteins and receptor-ligand interactions and for in silico modeling of small molecule therapeutics. Tertiary modeling of RNA structures has robust potential to guide the rational design of antiviral therapeutics [ 58 , 59 , 60 , 61 ]. Supportive evidence that alternative nt–nt pairings propagate structural changes throughout the HIV-1 leader RNA includes TAR-binding compounds exert structural effects outside TAR [ 62 , 63 ] and small molecule binding within the CES reduce virus titer [ 64 ].…”
Section: Discussionmentioning
confidence: 99%